(Q41729907)

8 October 2017

1 reference

title

Experimental and clinical methods in the development of anti-Alzheimer drugs (English)

1 reference

8 October 2017

0 references

Allain H

1

1 reference

8 October 2017

Bentué-Ferrer D

2

1 reference

8 October 2017

Zekri O

3

1 reference

8 October 2017

Schück S

4

1 reference

8 October 2017

Lebreton S

5

1 reference

8 October 2017

Reymann JM

6

1 reference

8 October 2017

publication date

1 January 1998

1 reference

Fundamental and Clinical Pharmacology

8 October 2017

published in

1 reference

8 October 2017

volume

12

1 reference

8 October 2017

issue

1

1 reference

8 October 2017

page(s)

13-29

1 reference

The role of estrogen in the treatment of Alzheimer's disease

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.1998.TB00919.X

The epidemiology of estrogen replacement therapy and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.1998.TB00919.X

Psychomotor function and psychoactive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.1998.TB00919.X

Drug treatments for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.1998.TB00919.X

Long-term tacrine (Cognex) treatment: effects on nursing home placement and mortality, Tacrine Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.1998.TB00919.X

The incidence of cerebral amyloid angiopathy in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.1998.TB00919.X

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.1998.TB00919.X

Do neuroleptic drugs hasten cognitive decline in dementia? Prospective study with necropsy follow up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.1998.TB00919.X

An intervention that delays institutionalization of Alzheimer's disease patients: treatment of spouse-caregivers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.1998.TB00919.X

A metaanalysis of controlled trials of neuroleptic treatment in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.1998.TB00919.X

The safety and tolerance of xanomeline tartrate in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.1998.TB00919.X

Cardinal features of cognitive dysfunction in Alzheimer's disease: a factor-analytic study of the Alzheimer's Disease Assessment Scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.1998.TB00919.X

RETRACTED ARTICLE: Amyloid plaques, neurofibrillary tangles and neuronal loss in brains of transgenic mice overexpressing a C-terminal fragment of human amyloid precursor protein

21 January 2018

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1038/354476A0

Identifiers

DOI

10.1111/J.1472-8206.1998.TB00919.X

1 reference

8 October 2017

1 reference